Dual Antiplatelet Therapy for Acute Stroke and TIA: Current Best Practice and Emerging Strategies
Published: 09 November 2020
-
Views:
8855
-
Likes:
7
-
Views:
8855
-
Likes:
7
-
28m 37sPart 6 Q&A and Summary
-
3m 16sPart 1 Chairperson’s welcome and introduction Pierre Amarenco
-
15m 12sPart 2 Secondary Prevention after Acute Minor Stroke or TIA: Understanding the Ongoing Risk Peter Rothwell
-
14m 30sPart 3 Current Best Practice: Evidence-Based Antiplatelet Therapy for Secondary Stroke Prevention Pierre Amarenco
Overview
This educational symposium was first broadcast in the joint European Stroke Organisation and World Stroke Organization (ESO-WSO 2020) Virtual Conference held 7-9 November.
The programme focuses upon emerging data and best practice in the use of antiplatelet therapy for the treatment of Acute Stroke and TIA
Learning Objectives
- To Highlight the Continued High Unmet Need for Strategies to Prevent Stroke or Death for Patients Experiencing Acute Stroke or TIA
- To Outline the Guidelines on the Use of Dual Antiplatelet Therapy for Patients Presenting with Acute Stroke or TIA
- To Examine Recent Evidence from Clinical Trials on Novel Strategies for Improving Outcomes for Patients Presenting with Acute Stroke or TIA and How These Data and Insights Can Be Applied in Clinical Practice
More from this programme
Part 1
Chairperson’s Welcome and Introduction
Part 2
Secondary Prevention after Acute Minor Stroke or TIA: Understanding the Ongoing Risk
Part 3
Current Best Practice: Evidence-Based Antiplatelet Therapy for Secondary Stroke Prevention
Part 4
Evolving Role of Dual Antiplatelet Therapy for Stroke Prevention: Advancing Best Practice for Patients at High Risk
Part 5
Clinical Decision Making for the Patient Presenting with Acute Stroke
Part 6
Q&A and Summary
| 1 session | |
| Q&A and Summary | Watch now |
Faculty Biographies
Clay Johnston
Prof Clay Johnston is Co-Founder and Chief Medical Officer at Harbor Health, Texas, US.
Previously, Prof Johnston was the inaugural Dean of The University of Texas at Austin Dell Medical School where he strived to advance a new model of better health care. He also served as a Professor of Neurology at the University of Texas at Austin and an Adjunct Professor of Neurology at the University of California, San Francisco. During his time at the University of California, Prof Johnston was Founding Director of the Center for Healthcare Value and was Associate Vice Chancellor of Research. Most of his research focuses on stroke care.